Evidence map›Paper›PMID 40842514›Full record

ArticleACS sustainable chemistry & engineering2025

Thermostable Enzyme Variants in the Lower Mevalonate Pathway Improve Isoprenoid Production by Cell-Free Biocatalysis.

Sylvia A Sarnik, Mia R Martinsen, Tyler P Korman, Daniel K Schwartz, Joel L Kaar, Yannick J Bomble

Abstract read
In one paragraph

Article in ACS sustainable chemistry & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sylvia A SarnikDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309, United States.
Mia R MartinsenBiosciences Center, National Renewable Energy Laboratory, Golden, Colorado 80401, United States.
Tyler P KormanExozymes, Inc., Monrovia, California 91016, United States.
Daniel K SchwartzDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309, United States.ORCID https://orcid.org/0000-0001-5397-7200
Joel L KaarDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309, United States.ORCID https://orcid.org/0000-0002-0794-3955
Yannick J BombleBiosciences Center, National Renewable Energy Laboratory, Golden, Colorado 80401, United States.ORCID https://orcid.org/0000-0001-7624-8000

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-free biocatalysis is a rapidly evolving field with great potential for sustainably producing valuable chemicals. Some challenges in cell-free biocatalysis include reaction longevity, enzyme stability, and the cost of the biocatalysts. Here, the challenge of enzyme instability was addressed by employing thermophilic enzymes to improve the productivity of the lower mevalonate pathway, using limonene as an example isoprenoid product. The Classical mesophilic mevalonate pathway was compared to a newly assembled set of thermophilic enzymes comprising the Archaea I mevalonate pathway. The thermophilic pathway enzymes were thermostable to at least 60 °C and exhibited a 6× longer operating lifetime at 22 °C. Thus, despite lower initial activity rates at ambient temperature, the thermophilic pathway was longer-lived and resulted in a more productive cell-free reaction overall, achieving 1.7× higher yield of limonene compared to using enzymes from mesophiles. Moreover, the thermostable pathway retained activity for longer with the challenge of solvent exposure, namely, ethanol and isoprenol, which broadens the scope of accessible substrates and/or products in cell-free reactions employing this pathway. Altogether, we showed significant improvement in the stability and productivity of the lower mevalonate pathway, which will enable more efficient cell-free biosynthesis of isoprenoid products. This represents a valuable strategy to increase the robustness of cell-free systems by carefully sourcing biocatalysts from thermophilic organisms, which have proven to be resilient to challenges unique to cell-free reaction systems.

Indexed as

cell-free biocatalysisenzyme stabilityisoprenoidlimonenemevalonate pathwaythermophilic pathway

Identifiers

PMID40842514
PMCPMC12365920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.